Le Lézard
Classified in: Health
Subjects: CCA, PET, FVT

Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement


GREENFIELD, Ind., April 17, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.

The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elanco's website at https://investor.elanco.com/events-and-presentations/default.aspx. A replay will also be available on the website shortly following the call.

ABOUT ELANCO 
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purposetm Sustainability Initiatives ? all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com.

Investor Contact: Katy Grissom +1.317.273.9284 [email protected]
Media Contact: Colleen Parr Dekker +1.317.989.7011 [email protected]

SOURCE Elanco Animal Health


These press releases may also interest you

at 10:30
Biocodex Microbiota Foundation Invites Canadian Academics and Scientists to Apply for ?25,000 Research Grant to Advance Microbiota's role Study in health and diseases
The Biocodex Microbiota Foundation, an organization founded by Biocodex and dedicated to inspiring scientific projects that explore the microbiome, is calling for grant proposals from innovative researchers at Canadian institutions. Biocodex...

at 10:30
Dental Bone Graft Substitutes Market Worth $1.8 billion | MarketsandMarketstm
Dental Bone Graft Substitutes Market in terms of revenue was estimated to be worth $1.3 billion in 2024 and is poised to reach $1.8 billion by 2029, growing at a CAGR of 7.7% from 2024 to 2029 according to a new report by MarketsandMarketstm. The...

at 10:30
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
USA News Group ? An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is being witnessed in Canada, the USA, and the EU,...

at 10:30
Pharmaceutical Glass Packaging Market to Attain a US$ 54.6 Billion Valuation by 2034, Grow at a 9.5% CAGR | Future Market Insights Inc.
The advancement path of the global pharmaceutical glass packaging market will be carved promisingly at a CAGR of 9.5%, enabling the market growth drivers to uplift the market from...

at 10:18
Olympus to Highlight Diverse Treatment Portfolio at American Urological Association Annual Meeting
Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, will highlight a diverse urology portfolio that can help physicians treat bladder cancer, urinary stones and enlarged prostate...

at 10:15
Countries With Low and Middle Income Populations are Exhibiting Comparatively Higher Demand for Barbiturate Drugs | Future Market Insights, Inc.
The...

More news about Health...


News published on and distributed by: